Home > Boards > US Listed > Biotechs > Cyclerion Therapeutics Inc (CYCN)

CYCN $4.5s revisited steadly moving higher as volume

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
dude iligence Member Profile
 
Followed By 380
Posts 10,637
Boards Moderated 3
Alias Born 03/04/06
160x600 placeholder
Small Company Offering and Sale of Securities Without Registration (d) Edgar (US Regulatory) - 6/17/2021 4:56:50 PM
Securities Registration Statement (simplified Form) (s-3) Edgar (US Regulatory) - 6/16/2021 4:49:00 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/7/2021 5:36:58 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/7/2021 5:26:24 PM
Amended Statement of Beneficial Ownership (sc 13d/a) Edgar (US Regulatory) - 6/7/2021 5:22:01 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/4/2021 4:38:30 PM
Cyclerion Therapeutics Announces $18 Million Private Placement GlobeNewswire Inc. - 6/4/2021 8:00:00 AM
Cyclerion Therapeutics Announces Global Licensing Agreement with Akebia Therapeutics for Praliciguat GlobeNewswire Inc. - 6/4/2021 8:00:00 AM
Cyclerion Therapeutics Announces Publication of CY6463 Preclinical Data in Frontiers in Pharmacology GlobeNewswire Inc. - 5/27/2021 4:30:00 PM
Cyclerion Therapeutics to Participate in Jefferies Virtual Healthcare Conference GlobeNewswire Inc. - 5/25/2021 7:00:00 AM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 5/19/2021 6:17:25 PM
Statement of Beneficial Ownership (sc 13d) Edgar (US Regulatory) - 5/14/2021 4:57:45 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/10/2021 8:45:56 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/4/2021 4:40:17 PM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 4/28/2021 7:01:53 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/27/2021 9:23:01 AM
Cyclerion Therapeutics Hosted Webinar to Discuss Pipeline Progress GlobeNewswire Inc. - 4/27/2021 9:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/26/2021 8:59:09 AM
Cyclerion Therapeutics Appoints Errol De Souza, Ph.D., to Board of Directors GlobeNewswire Inc. - 4/26/2021 7:00:00 AM
Cyclerion Therapeutics to Participate in the B. Riley Neuroscience Investor Conference GlobeNewswire Inc. - 4/21/2021 7:30:00 AM
Cyclerion Therapeutics to Host Pipeline Update Webinar GlobeNewswire Inc. - 4/20/2021 7:00:00 AM
TransMedics Appoints Stephanie Lovell to Board of Directors PR Newswire (US) - 3/24/2021 4:05:00 PM
Amended Current Report Filing (8-k/a) Edgar (US Regulatory) - 3/19/2021 6:05:12 AM
Cyclerion Therapeutics chief medical officer leaves Seeking Alpha - 3/18/2021 5:11:45 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 3/18/2021 5:01:25 PM
dude iligence   Monday, 03/02/20 03:47:51 PM
Re: dude iligence post# 11
Post # of 23 
CYCN $4.5s revisited steadly moving higher as volume increases. CYCN has explosive breakouts. The last one CYCN ran up to $6.25ish 49% in one day closing as biggest gainer on Nasdaq that day. CYCN been trading in a upward channel bouncing off the trend line. It held up very well last week in the market downdraft. The next leg should punch above the 200ma. How high we wont put a target on it just let it run. It should breakout above $4.83-$4.85ish.


In the time of this post pps now $4.61

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences